Personal Injury Lawyer
News & Events
Johnson & Johnson to Pay $700,000 in First Levaquin Trial
December 8, 2010 - A Minneapolis federal jury found that Johnson &
Johnson failed to properly warn of the risks of tendon damage for users
of its antibiotic, Levaquin. The jury awarded damages of $700,000 in the case.
J&J DePuy Hip Replacement Lawsuits Consolidated
December 4, 2010 - The judicial panel on Multidistrict Litigation ordered
that all federal lawsuits against Johnson & Johnson over recalled
DePuy hip replacment products be overseen by a federal judge in Ohio.
Jury Finds for Pfizer in Prempro Case
December 3, 2010 - Jurors in Virginia found that the Plaintiff, Georgia
Torkie-Tork couldn't show that Wyeth officials downplayed the breast-cancer
risks associated with Prempro, a hormone replacement drug.
Epilepsy Drug Used During Pregnancy Might Increase Spina Bifida Risk
December 3, 2010 - A new study indicates that women with epilepsy who are
taking carbamazaepine (Tegretol) to control their seizures may be at an
increased risk of having an infant with spina bifida. The report was published
in the December 3rd online edition of the British Medical Journal.
FDA Severely Limits Availability of Avandia
On September 23, 2010, the FDA announced that it would place significant
restrictions on patient access to the diabetes drug Avandia.
Wellbutrin Linked to Risk of Newborn Heart Defects
A study in the July 2010 edition of the American Journal of Obstetrics
& Gynecology suggests there may be an increased risk of having a baby
with a particular type of heart defect when the mother takes Wellbutrin
(buproprion) in early pregnancy.
More Than 4,000 Yaz/Yasmin Lawsuit Plaintiffs
As of September 2010, more than 4,000 Plaintiffs have filed lawsuits against
the drug companies who make the oral birth control pills Yaz, Yasmin,
Ocella and Gianvi.